LifeQuest World Corp. Announces Increased Sales Due to Swine Flu

* Reuters is not responsible for the content in this press release.

Wed Apr 29, 2009 9:02am EDT 

  LAS VEGAS, NV, Apr 29 (MARKET WIRE) -- 
LifeQuest World Corporation (OTCBB: LQWC) announced today that current
events have increased the public's demand for its immune enhancement
supplement, ImmunXT. Online sales at www.immunxt.com have been strong and
the company is increasing its production to meet such demands in the
event the swine flu virus continues to spread.

    In a world where life threatening toxic elements, dangerous environmental
pollutants, new potent viruses, drug-resistant bacteria and the constant
threat of pandemics, "Superbugs," chronic disease, allergies and food
borne illnesses have become daily news headlines, LifeQuest is pleased to
offer this powerful dietary supplement to support the immune system on a
daily basis.

    About LifeQuest World Corporation

    LifeQuest World Corporation Inc. is a life science company focused on the
global commercialization of unique, patented and scientifically proven
natural-source health products that allow for a proactive health
management approach while delivering the highest levels of effectiveness
and safety.

    The statements in the press release that relate to the company's
expectations with regard to the future impact on the company's results
from new products or actions in development are forward-looking
statements, within the meaning of the Private Securities Litigation
Reform Act of 1995. The statements in this document may also contain
"forward-looking statements" within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange Act of
1934. Since this information may contain statements that involve risk and
uncertainties and are subject to change at any time, the company's actual
results may differ materially from expected results.

    

LifeQuest World Corporation
P.O. Box 401654
Las Vegas, NV  89140
Tel:  702-914-9688 - after 5:00 p.m. 702-498-6409
Fax: 702-914-9625
Website:  http://www.immunxt.com
email:  info@immunxt.com

Copyright 2009, Market Wire, All rights reserved.

-0-
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.